These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10188730)

  • 21. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
    Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
    Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
    J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.
    Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM
    Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.
    Brown BS; Patanam T; Mobli K; Celia C; Zage PE; Bean AJ; Tasciotti E
    Cancer Biol Ther; 2014 Jul; 15(7):851-61. PubMed ID: 24755919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome-mediated therapy of neuroblastoma.
    Di Paolo D; Loi M; Pastorino F; Brignole C; Marimpietri D; Becherini P; Caffa I; Zorzoli A; Longhi R; Gagliani C; Tacchetti C; Corti A; Allen TM; Ponzoni M; Pagnan G
    Methods Enzymol; 2009; 465():225-49. PubMed ID: 19913170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
    Lundberg BB; Griffiths G; Hansen HJ
    Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
    Schwendener RA; Trüb T; Schott H; Langhals H; Barth RF; Groscurth P; Hengartner H
    Biochim Biophys Acta; 1990 Jul; 1026(1):69-79. PubMed ID: 2378882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
    Kawashima I; Tada N; Fujimori T; Tai T
    J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro.
    Ahmad I; Allen TM
    Cancer Res; 1992 Sep; 52(17):4817-20. PubMed ID: 1511445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells.
    Mehta RR; Hawthorne ME; Graves JM; Mehta RG
    Eur J Cancer; 1998 May; 34(6):902-7. PubMed ID: 9797705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy: a possible vaccine against tumors of neuroectodermal origin?
    Uttenreuther-Fischer MM; Krüger JA; Fischer P
    J Immunol; 2006 Jun; 176(12):7775-86. PubMed ID: 16751426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
    Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
    Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
    J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.
    Parsons K; Bernhardt B; Strickland B
    Ann Pharmacother; 2013 Feb; 47(2):210-8. PubMed ID: 23386066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
    Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
    Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.